This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
King Pharmaceuticals (niche pharmaceuticals) is buying Medco Research (adenosine-based therapeutics) in a stock swap, pooling of interest transaction that values Medco at $314mm. Each Medco common share will be exchanged for King common worth $30, a (pr)12% premium to the market average. Terms include a collar, and the ratio will be adjusted if King's trading price falls below $33 or above $49.87.
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?